Workshop B: Strategic Decision-Making & Closing the Gap in Dermatology
Time: 11:25 am
day: Pre-Conference Day
Details:
The immunodermatology landscape is rapidly evolving with new targets, modalities, and deeper pathway insights. Success depends not only on selecting the “right” targets and building a future-ready pipeline but also on ensuring that approved therapies reach eligible patients. This integrated session brings together strategic R&D decision-making and real-world implementation challenges to provide a holistic view of innovation and access in dermatology.
Key Objectives
- Prioritize Targets and Pathways: Define criteria for selecting interleukins, immune cells, and mechanisms, leveraging translational insights and early clinical validation
- Design Future-Ready Pipelines: Shape dermatology portfolios strategically—balancing commercial opportunity, patient needs, and long-term differentiation
- Evaluate Innovation & Impact: Apply frameworks to assess clinical and commercial potential, ensuring candidates deliver meaningful innovation and internal buy-in
- Bridge Approval to Access: Address market access, pricing, reimbursement, and adoption barriers; enhance clinician engagement and patient inclusion to close treatment gaps
*Lunch will be served during this workshop at 12pm
Speakers:
